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Abstract 
The initial focus is directly related to tort-law and the liability associated with making medical 
mistakes in a tort case.  Our study originates on the idea that a patient advocate, with the 
patients’ best interest in mind, would also serve the role as a risk management program, 
protecting and ensuring safety for patients and healthcare professionals alike.  Through a basic 
professional opinion survey study, patient advocates will be asked a series of questions giving 





       
Literature Review 
Young consumers in western culture, in the United States specifically, according to a new 
Accenture survey, determined that Gen Z (born 1997 onward) healthcare consumers are not 
satisfied with the business and status quo of traditional healthcare.  There is a clear trend 
showing a shift towards non-traditional healthcare services received by younger consumers.  The 
Accenture 2019 Digital Health Consumer Survey was launched to investigate and study this 
trend.  What they found was worth taking note.  Healthcare marketing professionals are starting 
to see a shift in engagement in virtual care, retail walk-in clinics and other non-traditional 
healthcare practices. The Safavi & Kalis survey study (2019) suggests that around 55% of Gen Z 
and around 67% of Millennials are likely to have a primary care physician.  That means Gen Z 
and Millennials are significantly less likely to utilize traditional healthcare techniques in 
comparison to other generations that do utilize primary care physicians such as Gen Xers (76%), 
Baby Boomers (84%) and the Silent Generation (85%).  The study is quick to suggest the 
hypothesis that as Gen Z and Millennials continue to utilize non-traditional healthcare 
techniques, non-traditional styles of healthcare will continue to evolve and become more popular 
among all ages (Safavi & Kalis, 2019).  The study proceeds to suggest that an estimated 29% of 
survey participants say they have utilized some form of virtual care which is a significant 
increase compared to an estimated 21% in 2017 (Safavi & Kalis, 2019).   
As our healthcare system continues to evolve at such a rapid pace, patient satisfaction and 
patient-centered care will remain a constant.  As we strive to exceed the limits of healthcare 
techniques and professional healthcare delivery styles, policies and standards will continue to 
shape our healthcare system.  With new policies and standards continuing to mold this 
profession, advocacy for both patients and professionals will become a prominent role in 
       
healthcare facilities (Blankenship & Duffy, 2015).  An active internal patient advocacy program 
would facilitate the transition into non-traditional styles of healthcare, for the eHealth transition 
has begun globally (Black et al., 2011).  According to the review, Black et al. (2011) eHealth 
technologies offer patients a variety of benefits including: storage, management, and 
transmission of health information; clinical decision making to receive more support from other 
professionals; and thirdly, the professional’s ability to facilitate care from a distance.  
Documents, assessments, and health history, all can be shared with the approval of the patient 
which then allows the patient to receive professional opinions from a wide variety of healthcare 
professionals; thus, expanding the efficiency of the patient’s progression towards treatment 
goals.   As this study continues, the role of patient advocates and patient advocacy programs (or 
PAOs) will be investigated to strengthen the context of the desperate need for direct advocacy 
for, not only, patients but also healthcare delivery professionals (Blankenship & Duffy, 2015).  
This study will research the role of a patient advocate or advocacy program as a risk 
management program in traditional health care facilities compared to non-traditional facilities 
in a rapidly evolving health care services and medical technology advancements in the Western 
culture: through a functional lens.   
Patient Advocacy.  A patient advocate’s role in the healthcare system can be highly 
misunderstood and not conceptualized to its entirety in healthcare facilities; thus, creating a 
significant gap between the concept of a patient advocate role or patient advocacy program and 
the reality of an active patient advocate role or patient advocacy program (Abbasinia, Ahmadi, & 
Kazemnejad, 2020). 
Blankenship and Duffy (2015) identify three types of advocacy.  The first general type of 
advocacy directly relates to specific patients or groups of patients who; for example, lack 
       
insurance or the resources to obtain medical care such as elderly adults and children.  The second 
type of advocacy also relates to advocacy for patients.  The focus of this type of advocacy is to 
ensure that all patients receive high quality services; for example, patient-centered decision 
making, ensuring appropriate availability, and use of available resources.  This style of advocacy 
is often defined as a professional’s ethical responsibility given their professional understanding 
of current clinical and healthcare system issues (Blankenship & Duffy, 2015).  The third type of 
advocacy is not for patients.  In fact, Blankenship and Duffy (2015) suggest a unique style of 
advocacy; advocacy for professional societies.  The authors suggest that the advocacy for 
individual professional societies indirectly promotes advocacy for patients and professionals who 
the professional society governs.  Blankenship and Duffy (2015) proceed to argue that indirect 
advocacy; perhaps, needs to be more direct given the rapid transitions and challenges that 
healthcare providers face.  Specifically, the rapid transition to telemedicine.   
Mackey and Schoenfeld’s (2016) scientific study suggest that as patients and families 
continue to gravitate to online healthcare campaigns, issues begin to appear stemming from 
mixed results of patient satisfaction surveys.  Their article released on BMC Medicine shines 
light on a new form of “digital” patient advocacy concerned directly with issues pertaining to 
any patient confusion or frustration, ensuring reliable information about treatment options, and 
addressing current limitations with the structure of online healthcare delivery, ensuring all 
patients are satisfied with their healthcare service.   
Koay & Sharp (2013) conducted a social research study focusing on the role of patient 
advocacy organizations emerging parallel to the exponential growth of medical research and 
development.  Koay & Sharp (2013) characterize patient advocacy organizations (PAO) as the 
advocate’s “efforts… to give patients a greater voice and ensure that patients’ interests are 
       
acknowledged by those in positions of power” (2013).  They continue to provide evidence 
highlighting the advocacy for the practicing professionals by drawing attention to the PAO’s 
collaboration with medical and healthcare professionals.  Koay & Sharp argue that the 
relationship between the two professionals is important for the facilitation of the “PAOs work in 
advancing the science not only by raising public awareness… and supporting research through 
philanthropic efforts, but also by participating in the design and conduct of [their] research” 
(2013).  The researchers proceed by pointing out the difficulty of singularly defining PAOs; 
however, they suggest that reviewing specific previous PAOs facilitates a greater understanding 
of a PAO’s mission and structure (Koay & Sharp, 2013).   
Susannah Rose, an Associate Professional Staff member in the Department of Bioethics 
at the Cleveland Clinic, released a research article to The Journal of Law, Medicine & Ethics 
revealing the efficiency of a highly understood patient advocacy program within a healthcare 
facility (Rose, 2013).  Further dissection of the article reveals Rose’s (2013) efforts to highlight 
the institutional barriers; such as interest, trust, and trustworthiness, faced by PAOs in their 
efforts to provide facilitation for transitions into new, patient-care protocols and caregiver-
oriented education.   These barriers often create a conflict between PAOs and the 
medical/healthcare professionals that interfere with the PAO’s role that is discussed in the Koay 
& Sharp study.  Barriers and professional conflicts between PAOs and licensed professionals 
disrupt the flow of the PAO’s data collection, analysis, and disseminating the results (Koay & 
Sharp, 2013).  The disruption in the flow of a PAO’s role subjects respective parties to become 
uncertain in the legitimacy, authority, and organization of the researcher’s protocol.  
Furthermore, the Koay and Sharp study (2013) identifies PAOs as a safeguard for patients 
ensuring boundaries, identities and representation of the patient’s voice is present; likewise, 
       
protect the practicing professionals from legal issues that stem from frequent patient-caregiver 
relationships such as informed consent and tort law.  
Legal Issues.  Lawsuits surround all health service professionals including; surgical doctors, 
medical doctors, general healthcare providers, and all other healthcare employees. Medical 
malpractice is a very serious issue for both healthcare providers and patients. In fact, errors that 
lead to medical malpractice occur during all stages of the healthcare process, such as the 
diagnostic stage, the treatment stage, and/or the post discharge treatment (Shipley, 2018).   
The American Board of Professional Liability Attorneys (ABPLA) defines medical 
malpractice as “when a hospital, doctor or other health care professional, through a negligent act 
or omission, causes an injury to a patient” (ABPLA, 2020).  Likewise, researcher Melinda 
Cooper (2011) calls attention to the modern experimental method of research, which she 
identifies, was established in the seventeenth century and was later refined by the term ‘clinical 
trial’ which became popular during the mid-twentieth century.  Cooper’s paper (2011) calls 
attention to the rapid advancements in clinical research to raise awareness of the increase in 
regulation of malpractice or accidents (tort law) that arise from practicing new forms of 
healthcare delivery. 
Rebecca Dresser, the Daniel Noyes Kirby Professor of Law and Professor of Ethics in 
Medicine at Washington University in St. Louis, released a book in 2001 titled “When Science 
Offers Salvation: Patient Advocacy and Research Ethics.”  Dresser uses her platform to identify 
the immeasurable limits of the role of a patient advocate or advocacy program within a 
healthcare facility.  She identifies specific roles such as the advocate’s role in the rapidly 
changing research environment, the role in shaping and assessing science research, expanding 
access to experimental interventions, an advocate’s role to be the voice of the public or 
       
individual patient, and also discusses the recurrent themes faced by advocates in healthcare 
delivery settings.  Dresser’s discussion on the role of advocacy draws attention to the role of 
patient advocates or patient advocacy programs’ service to provide risk management to protect 
practicing professionals from the legal side of their practice and also assist in supporting the 
healthcare professional’s obligation to provide the highest level of care and recommendation 
services to their patients.  Dresser (2001) suggests that a new breed of advocacy has gained 
popularity in healthcare administration settings.  This new form of advocacy joins forces with 
scientists, doctors, clinicians, nurses and other healthcare professionals to represent patients and 
the public interest to retain the highest satisfactory and safest experience for patients to receive 
healthcare treatment.  Dresser’s identification of this new form and the new role of advocacy 
points in the direction of an advocate’s inclusion in the administration body of healthcare 
facilities as a risk management program as scientific research continues to rapidly evolve and tort 
law continues to be an issue for practicing professionals.   
Tort law is often used as an umbrella term to define all of the regularities in malpractice 
lawsuit cases.  As healthcare professionals continue to conduct research and clinical trials, the 
term ‘evidence-based practice’ becomes more developed with each study; however, achieving 
those answers requires risks that lead to tort cases (Cooper, 2011).  With each new study, a 
multitude of additional studies stem from one specific study; therefore, improving our 
understanding of the natural world around us.  Mackey and Schoenfeld (2016) released an article 
studying this rapid transition.  Their study specifically studies the transition into telemedicine 
and digital healthcare delivery techniques and identifies the variety of tort cases that inevitably 
result from this transition.  With telemedicine and eHealth becoming more popular amongst 
younger generations, Mackey and Schoenfeld (2016) call for a new form of advocacy: ‘digital 
       
advocacy’ which directly combats the legal issues and tort law cases that a healthcare delivery 
professional may experience.  Neglecting this rapid transition and failing to retain an updated 
knowledge of the legal policies and standards will result in many practicing professionals facing 
legal issues.  Mackey and Schoenfeld’s study’s forecast on this call to this new form of digital 
advocacy indirectly shines light on the justification of a more developed role of a patient 
advocate in traditional care facilities.  As we proceed, the different types of tort law will be 
discussed and the risk management that a patient advocate role can provide in a healthcare 
setting will be discussed.  Tort law consists of three parts; intentional torts, negligence and strict 
liability/liability insurance.  First, let’s discuss intentional torts. 
Intentional Torts.  Intentional tort cases stem from medical professionals practicing their 
profession in a way that is outside of governing protocols and policies.  Allen & Allen, define 
tort as a “wrongful act resulting in injuries or damages,” the injured person “may seek recovery 
from the person who caused the injury” (Allen & Allen, 2018).  In many cases the patient is 
accusing the facility or health professional of wrongful conduct; therefore, the accuser is 
considered the plaintiff in these cases.  In healthcare litigation and standards of practice today, 
intentional torts do not necessarily constitute a crime or criminal action by the healthcare 
professional (2018).  Allen and Allen (2018) identify intentional torts as a civil crime; however, 
in the courtroom, an intentional tort is much more liable to become a criminal offense compared 
to a negligent action.   
Gerhard Wagner (2012) released an article to the Duke Journal of Comparative & 
International Law covering lessons learned from real world experiments that stem from tort and 
no-fault schemes.  Wagner studies reveal that in modern healthcare, the tort system, specifically 
the intentional tort system has flaws and “consumes a large fraction of the money… in the form 
       
of court and lawyers’ fees instead of allocating the funds to victims for the purpose of 
compensation” (2012).  Wagner suggests a new system identified as the ‘No-fault scheme’ which 
seeks to award tort victims a larger share of the costs included in the tort lawsuit; however, this 
scheme is flawed, for Wagner suggests that this new scheme serves as a deterrence and when the 
patient’s health, body, and condition of either life and death are at stake, the effect of the larger 
sum of incentives is much smaller than anticipated, for more collateral does not repair or replace 
the damage that has been done.  A recent study by Rubio et al. (2020) suggests that 
undergraduate education programs for healthcare students need to be taught more skills and legal 
issues; a specialty of a patient advocate role.  Rather than focusing on providing the patients with 
compensation for ethical or legal wrongdoing, Rubio et al. (2020) analysis suggest that palliative 
care education is essential for healthcare workers to achieve their goal of “reliev[ing] the 
suffering of patients and their relatives through an integrated treatment of the physical and 
psychosocial symptoms and to deal with their spiritual needs” (Rubio et al., 2020).  This analysis 
suggests that palliative care education improves the diversity of training and the diversity of the 
highest ethical and legal care provided to all patients; not only patients receiving palliative care.  
This form of diversity in training directly defines the role of a patient advocate in terms of the 
previously discussed study performed by Blankenship and Duffy (2015) that would not only 
advocate for the well-being of the patients and relatives, but also provide risk management 
protection for the practicing professionals.  Secondly, this form of education as a risk 
management program provides an awareness and protection platform for more than just 
intentional torts, but also the second form of tort cases we will be discussing; negligence.  
Negligence.  The American Bar Association defines negligence as a person’s “liability 
stem[ing] from careless or thoughtless conduct or a failure to act when a reasonable person 
       
would have” (American Bar Association, 2016).  Negligence becomes an issue when the legal 
duty was not met by the professional and there is a failure to comply with the standard or policy 
in place (2016).  The American Board of Professional Liability Attorneys (ABPLA), the top 
medical malpractice attorneys in America, define medical malpractice in terms of negligent 
actions.  Negligent actions can occur during many stages of the healthcare delivery process from 
“errors in diagnosis, treatment, aftercare or health management” (ABPLA, 2017).  Negligent 
actions by healthcare professionals have the potential to cause a variety of risks; ranging from, a 
violation in the standards of care provided by governing bodies, injuries resulting from negligent 
actions, significant damages to the patient involved in the negligent; or perhaps, providing a 
healthcare service that is no longer accepted and recognized by national governing bodies: this is 
known as malpractice in most cases (2017).  Specific examples provided by ABPLA (2017) 
include, “failure to diagnose or misdiagnosis, misreading or ignoring laboratory results… 
improper medication or dosage, poor follow-up or aftercare, premature discharge, disregarding 
or not taking appropriate patient history, failure to order proper testing, failure to recognize 
symptoms,” etc.  In an attempt to limit acts of negligence, recent findings suggest that the role of 
patient advocate can help to supplement to improve patient’s experience and safety in the 
healthcare delivery setting.  A recent study by Katz et al (2012) suggests that a patient advocate 
assists in the treatment process by ensuring: patients have informed consent; promoting patient 
accrual with regards to procedures, eligibility, and cultural considerations; identifying the ethics 
of practice in the healthcare setting; and promoting patient and employee safety and 
confidentiality throughout the treatment process.  The Katz et al (2012) online survey suggests 
that of those surveyed, only a minority of patient advocates reported having questions directed 
towards them in committee meetings; however, most of the participants reported that the 
       
comments by patient advocates are considered and valued in treatment team meetings.  
Continuing on, let’s discuss how patient advocates or PAOs can also serve to reduce liability in 
healthcare facilities and reduce the increase in liability insurance associated with intentional torts 
and negligence.   
Tort Liability and Liability Insurance.  As discussed in previous paragraphs, many 
lawsuits surround health service professionals including; surgical doctors, medical doctors, or 
general healthcare providers.  In 2011, Daniel P. Kessler, a Professor of Law at Stanford School 
of Law released an article titled “Evaluating the Medical Malpractice System and Options for 
Reform.”  In his article, Kessler highlights the two principle objectives for our liability system; 
“to compensate patients are injured through the negligence of healthcare providers and to deter 
providers from practicing negligently” (2011).  Kessler identifies multiple issues the modern 
liability system has including, “fail[ing] to compensate who have suffered from bad [health] 
care and compensate[ing] those who haven’t” (2011).  In turn, the lawsuits that surround 
healthcare and liability issues have inflated coverage prices for many parks & recreation 
facilities, sports facilities, and professional health-service providers as a whole.  Most of these 
cases are directly correlated and made possible by the plaintiff by “tort law” and can occur with 
very large financial costs; especially considering the uninsured nonfinancial costs associated 
with these cases (2011).  Researcher Joseph Thomas, who conducts research for Kasturba 
Medical College in Manipal, India, released an article in 2009 declaring an imperative that 
present-day medical doctors and healthcare providers must continue ‘medico-legal’ education 
(2009).  With these ethical and legal interpretations changing at such a rapid pace, there is lots of 
room for an intentional tort or negligent action to occur within the system causing many legal 
issues to arise if the correct policies and guidelines for continuing education are not set in place 
       
by a healthcare facility.  Incorporating risk management and maintaining an effective doctor-
patient relationship, a facility should invest in focusing on mandating a continuing education 
program, through a PAO or patient advocate, to assist professionals in maintaining awareness of 
the “legal issues…include[ing] the basics of medical negligence, changing concepts of informed 
consent, and the practical issues of medical negligence cases” (2009).  The more a facility and 
its professionals retain awareness and receive education of the evolving standards and policies, 
the more prepared a facility can be to prevent or limit harmful experiences for employees and 
patients mutually.  Often, there is a negative stigma around continuing education and 
recertification for many professionals; however, neglecting the constant change in practice and 
company guidelines will result in a decision “favor[ing] the patient who has suffered due to the 
negligent action of the doctor” (Thomas, 2009) or medical professional in any case filed against 
them for incorrect interpretations of ethical and legal governing standards and policies. 
Introduction 
Patient advocates and patient advocate programs play a vital role in healthcare today.  
Advocates of this form provide a voice for patients and provide patients with information that is 
not discussed with them or is explained in terms that may be over a patient’s head.  Many 
administration professionals associate the role a patient advocate or advocacy program exercises 
in a healthcare facility to doctors, nurses, or technicians in healthcare settings; however, it is 
apparent that professionals in these roles are focused on duties and job roles required by their 
main role in the treatment team.  Furthermore, a patient advocate expands on these roles as a 
source to inform the service population within the community while the healthcare delivery 
professionals maintain focus on improving the care and quality of life of their patients.   
       
Additionally, the role of a patient advocate or patient advocate program could provide 
protection to the practicing professionals within the facility by advocating for not only the safety 
of the patients but also advocating for the legal and ethical practice of the professionals.  The 
patient advocate or advocacy program ensures the patients receive the highest level of care while 
maintaining legal and ethical standards and expectations that evolve as rapidly as the practice of 
healthcare delivery services.  In western-culture healthcare delivery, often times doctors, nurses, 
and other professionals are focused on the well-being of all of their patients who are desperate 
for their level of professionalism.  The role of the patient advocate is to ensure the safest 
experience for the patients receiving care.  As we dig deeper into this study, we will begin to 
investigate the existing roles of a patient advocate or advocacy program within a healthcare 
facility.  Our goal with this investigation is to survey patient advocates and receive their 
feedback and professional opinions on their specific role within their facility.  Additionally, the 
intention of this study is to determine whether or not their advocacy role could be expanded on 
as a risk management program at an administrative level in their respective healthcare delivery 
setting; traditional and non-traditional.  
Methods 
Participants.  Approved by the Oklahoma State IRB, participants will be selected based on a 
brief screening process involving a Linked-In profile screening search.  The goal of the 
researcher is to identify approximately 30 ‘patient advocates’ who work in a health-care related 
field.  Participants must be adults working in the United States.  The researcher intends to 
diversify the sampling population as much as possible including patients who are advocates for 
their own health as well as patient advocates who work under a non-profit or advocacy 
organization through a snowball sampling method.   
       
It is understood that therapists in the healthcare setting are indirectly advocates for their 
patients; however, the overall goal of this study is to hone-in specifically on professionals who 
have the job title of ‘patient advocate’ to research the role of patient advocates in their 
administrative role.  It is also the goal of the researchers to gain insight on whether or not 
professional ‘patient advocates’ believe their role is sufficient for their job title.  By receiving 
their professional opinions through a survey study, the researcher seeks to better understand the 
specific role of a patient advocate and evidence that suggests a ‘patient advocate’ position should 
be expanded on in their respective healthcare facility.  Through a variety of participants gathered 
by the snowball sampling method, a diverse understanding of roles of patient advocates will be 
analyzed, and a diverse data set will allow the researcher to analyze the unique ways patient 
advocates believe their role could be expanded on.   
Survey.  Similar to the Katz et al (2012) research study, a survey will be administered surveying 
and assessing the perceived role and the value that patient advocates have in their discipline.  
Using the snowball sampling method, the researcher intends to connect with professional patient 
advocates through Linked In and use participants professional network to identify other patient 
advocates working in healthcare.  The researcher seeks to investigate the perspectives and 
professional opinions of patient advocates or representatives of patient advocacy programs in 
their respective facility.  Using the survey platform ‘Qualtrics,’ a 38-item survey will be 
administered to participants identified as patient advocates.  Other requirements are not required 
for survey participation; however, the researcher seeks to investigate the different administrative-
influence levels patient advocates have within their administration team.  Questions in the survey 
are originally created by the researcher and orient towards eliciting professional opinions of the 
pros and cons of the role of patient advocate in western healthcare systems today.  The goal is to 
       
understand these roles, and learn new techniques or ideas to qualitatively enhance the role of a 
patient advocate role as a risk management position.  To increase the number of participants for 
this study, participants of the study will be asked to use their network of patient advocates to 
snowball the group of patient advocates participating in the study.   
Data Analysis.  Questions in the survey will be grouped in sections that answer a handful of 
questions.  The grouping format will be utilized to analyze the professional opinion of a handful 
of questions all related to one specific role and/or participation in one part of the treatment 
process.  First the study will ask participants if they are currently at a facility that employees a 
patient advocate or utilizes a patient advocacy program, followed by a group of questions to 
investigate co-existing roles that the patient advocate may have in the treatment team, such as a 
direct-care employee (a therapist, nurse, etc.) or an indirect care employee (administrator, intake, 
etc.).  This set of questions will validate the specific job role that the participant was hired for; 
furthermore, validate questions of this investigation that may suggest that certain primary job 
roles are the primary focus for that job prior to their role as a patient advocate.  The survey will 
continue with this format, asking questions in different groups to answer specific questions that 
will be addressed and analyzed in the results section.  Using an exploratory data analysis method 
to analyze the survey results, the insights and opinions of professional patient advocates will be 
interpreted and patterns within the results will be discussed to understand the role of professional 
advocates in western healthcare today.  Using our inferential statistical analysis method, the 
researcher also seeks to explore the visions and insights that participants have for developing a 
stronger, well-rounded patient advocacy program and atmosphere within their facility.  The 
researchers intend to utilize the Chi Squared test to score the fit of the original hypothesis.  To 
use this test with unbiased results, the test requires a minimum of 5 cell counts.  If the minimal 
       
thresh-hold of 5 participants is not met to use this test of best-fit; however, the researcher will 
utilize a case report style to analyze the responses of the participants and make inferences based 
on each individual participant’s response.  
Results 
Case Report.  After a two-week recruitment and data collection period, three professional 
patient advocates participated in the study.  The goal of achieving 30 participants was not 
achieved; likewise, the minimum thresh-hold for the Chi Squared best fit was not achieved.  The 
researcher, therefore, will utilize a case report style to make inferences based on the responses of 
each individual participant.  Reluctantly, our participating patient advocates all embody entirely 
diverse roles as a patient advocate.  Each participant’s response will be analyzed to compare the 
differences and identify similarities in responses to survey questions.   
Participant 1.   The first participant was a patient advocate working in a non-traditional 
patient advocacy setting, specifically, the participant works for a pharmaceutical company.  This 
style of advocacy is non-traditional because it is western-healthcare based; a non-traditional 
practice from a global standpoint.  This participant’s specific role engages directly in advocating 
for patient focused drug development (PFDD) and seeking outreach to receive patient feedback 
loops.  It is not clear whether or not, but worth taking note, the patient advocate in this setting 
does not play a part in the discharge process.  The participant did not distinguish a definitive 
response; therefore, this can only be noted as an inference.  It is also worth noting that this 
participant does not believe that other administrative roles understand the role of the patient 
advocate.  This raises a flag, because if administration doesn’t understand the role of their patient 
advocate, it raises questions on how that administration could make internal changes based on 
the professional assessment of a position they do not understand.  This participant also reports 
       
that other administrative roles do not understand the patient advocacy program that the 
participant serves.  In this pharmaceutical setting, the patient advocates seem to be less directly 
working with the patients, the patient advocate respondent for this survey reports that the patient 
advocate is not a direct care employee, such as a therapist, nurse, etc.  This could be an 
interesting aspect to consider.  With this patient advocate not having a co-existing role in the 
facility, it raises questions to whether this role can achieve more as an advocate, with no other 
job role commitments; whereas, a direct-care employee also must focus on those job duties.  
Alternatively, a direct-care employee who is also a patient advocate could offer advocacy more 
directly representative to the service population if they are directly caring for them and 
developing a more in-depth report with the patients they are advocating for.  This avenue of time 
in comparison to our understanding of the role of patient advocate is definitely something worth 
researching more; however, not significantly investigated in this study.   
Participant 2.  The second patient advocate participant in this study works in long-term 
care, assisted living and skilled nursing.  This participant’s free response to their professional 
opinion on how to achieve the most optimal programming for the patient advocacy program at 
their facility is interesting and worth investigating.  At the beginning of the survey, the 
participant classifies as an indirect care employee; likewise, reports that in the role of patient 
advocate, isn’t on the facility’s cite most days of the week.  This raises questions to the 
researcher of the ability of the patient advocacy program to function in this facility; however, the 
free response facilitates an inferenced answer to those questions.  The participant believes that 
the “advocacy program should not be an ‘in house’ one.”  Furthermore, the participant believes 
that the advocacy program should be represented by a 3rd party and is resident and/or patient 
directed meaning that the advocates for the program itself are merely representative of the 
       
patients themselves.  This approach is very interesting and worth taking note of; however, the 
participant still notes that other administrative roles are not educated on the specific role of the 
patient advocacy program within the facility.  This could be a result of the PAP being ‘out-of-
house’ or 3rd party; however, again, this ties into the same questions drawn from Participant 1.  
Are these indirect-care employed advocates able to achieve more advocacy work for their clients 
working solely as an advocate or is this simply a difference caused by the service population 
these advocates are working for?  Additionally, this draws new questions based on the responses 
of the participant.  Are ‘out-of-house’ advocacy programs more efficient than ‘in-house’ 
programs?  Are ‘out-of-house’ programs able to litigate policy within the organization by being 
3rd party?  Again, these are new questions drawn from the research performed in this study that 
should be investigated with further research.   
Participant 3.  The third participant in the professional opinion survey is a patient 
advocate who also works as a direct-care employee as a therapist in mental and behavioral 
health.  Similar to the other participants, this participant reports that the facility might or might 
not benefit from a well-rounded patient advocacy program within their facility.  Compared to the 
other participants, the patient advocate working also as a direct-care therapist, participates in the 
patient discharge process and actually administers the discharge satisfaction survey.  This 
participant’s response is intriguing because the patient advocate is receiving direct feedback 
about overall satisfaction of the patient’s overall experience and satisfaction feedback on each 
discipline within the facility; doctors, nursing staff, technicians, etc.   Additionally, in 
comparison to the other respondents, this participant specifically reported that the patient 
advocacy program in a mental and behavioral health facility has no problematic limits.  
Similarly, in comparison to the other responses, the third participant reports that the 
       
administrative role of the patient advocate is understood by other administrative roles; likewise, 
the specific role of the patient advocacy program is well understood by the other administrators 
employed at the facility.  It is important to note that participant three, who is also employed as a 
direct-care therapist, answered ‘Agree’ to more questions within the survey compared to the 
other participants.  From the responses reported by participant number three, it can be inferred 
that based on our primary sample population, this patient advocate has the most administrative 
participation within their facility compared to other respondents.  Counter-argumentatively, this 
survey participation draws on the same questions as the drawn by the responses of the other 
participants’ responses.  Participant three offers a counter argument because the patient advocate 
is a direct-care employee, and the patient advocate scored the highest and showed the most 
variety in specific job roles within the facility, including participating in treatment team planning 
and patient discharge planning.  Are direct-care employees able to get a more direct and personal 
feedback from patients?  Is an ‘in-house’ patient advocacy program more administratively 
efficient than an ‘out-of-house’ program?  Similar to the former, these are questions that should 
be addressed and investigated through further research. 
Similarities.  The survey participants’ responses had similarities that are positive notes and can 
be represented through graphic analysis.  Questions within the survey start off with some basic 
screening questions to ensure the facility has a patient advocate or patient advocacy program.  As 
the questionnaire continues, questions get more and more below the surface level of describing 
their job role; for example, the patient advocates respect by other administrators, participation in 
administrative meetings, participation in treatment planning, role as a risk management program, 
role to protect both patients and professionals, etc.  Below you will find Figure 1 describing 
some of the similarities within the participants’ responses.   
       
 
 All Agree.  Throughout the survey, there were many differences between the participants 
including the setting participants are employed in, their specific role within their facility and 
other questions that were answered differently; however, the similarities are relevant and 
applicable to the study.  First all three participants agreed that the Patient Advocacy Program 
within their facility also serves as a risk management program.  The similarities in answers to 
this question are important to note because the patient advocacy program should serve as a risk 
management program for patients and professionals.  Although, not all patient advocates may 
play a role in their facility’s risk management program, it is important to note the impact of 
All Participants (1,2, & 3)
All Agree
Facility's Patient Advocacy 
Program serves as risk 
management program.
Patient Advocate/Patient 
Advocacy Program ensures safety 
and satisfaction of all patients.
With the appropriate resourses, a 
effective and more developed 
Patient Advocacy Program could 
benefit patients and practicing 
profesionals.
Patients and professionals would 
benefit from a patient 
advocate/PAP role in patients' 
treatment planning.
Two Agree
Patient Advocacy Program also 
provides advocacy for the 
facility's practicing professionals.
Patient Advocacy Program serves 
a role in providing protection for 
the facility as a whole.
Facility's patient advocate/PAP 
representative attends meetings 
and recommendations of 
advocate are considered by 
administrative team. 
       
patient advocacy programs within different respective facilities.  Likewise, the respondents all 
agreed that the patient advocacy program also elicits a safe and satisfactory experience for all 
patients receiving treatment.  And furthermore, all participants agreed that with the appropriate 
resources, a better developed program could be implemented in the facility.  This question is 
kind of unique and draws questions that should be further investigated.  Is the patient advocacy 
program actually less developed from lack of budget funds or lack of perceived importance 
within the facility? Or is the program well developed and the representatives of the program 
believe it could be just that much better?  The latter, suitably, a better question that should be 
investigated on new techniques and methods to achieve a higher functioning patient advocacy 
program.  Finally, another important similarity within the results suggests that the participants of 
the study agree that the patient and multidisciplinary team would benefit from the patient 
advocate/PAP’s participation in treatment team planning meetings.  This is pretty clear and 
straightforward, the patient advocate should play a role in the treatment team meetings, for the 
sole role of the patient advocate is to advocate for their patients.  With the numerous stages of 
the treatment process, the patient advocate should be able and willing to represent their patient in 
treatment planning meetings.   
 Two Agree.   Moving down to the bottom half of Figure 1, the researcher found 
interesting results for some of the answers that only two of the participants agreed on.  The 
differences within the setting of employment was not considered for this discussion; however, 
each question set with two ‘agrees’ will be subject to a counter-argument by the researcher.   
 The first notes from this analysis was that two out of the three respondents report that the 
patient advocate or advocacy program advocates for the protection of the practicing professionals 
and the facility they serve, as a whole.  This is interesting because it brings light to the 
       
participant that disagreed with these two questions and leads to further questions to be drawn by 
the researcher.  Is the patient advocacy program being limited at an administrative level or 
corporate level?  How would the patient advocate/PAP advocate for expansion of their role to 
advocate for protection of the facility and all members of the multidisciplinary team, including 
the patient?  It would be interesting to analyze this result from a larger sample population to see 
the similarities from a much larger group.  
 Finally, the third blank in the ‘two agree’ category is actually interesting at the fact of not 
having all three agrees.  Two respondents agreed that the patient advocate/PAP representative 
attends administrative team meetings and recommendations brought up by the patient advocate 
are taken serious and seriously considered.  It is interesting to note that the other participant did 
not ‘Agree’ to this survey question, and again leads to a group of questions that should be 
considered.  Why isn’t the patient representative attending administrative meetings?  If patients 
are first, who represents the patients in administrative meetings?  Similar to the prior ‘Two 
Agree’ discussion, the counter-argument, or the participant that disagrees, draws more secondary 
questions that should be addressed with further research.   
Discussion 
Recommendations.  First and foremost, the researcher recommends a larger sample population 
of patient advocates for future research investigations.  The primary problem faced when 
recruiting participants was the study plan to utilize Linked-In to gather research participants.  In 
order to collect participants from the Linked-In platform, the researcher was required to 
‘Connect’ with other platform users and build up a personal network to connect with similar job 
roles in patient advocacy.  A large amount of time during the data collection period was spent 
recruiting potential participants, who were primarily unlikely to connect with a Linked-In 
       
member, like the researcher, with under 100 connections and no professional experience.  With a 
larger time-frame for data collection, patient advocacy groups could be utilized to collect 
participants and achieve a survey pool of around 50-75 patient advocates.  Furthermore, during 
the recruitment process, the researcher gained insights through seasoned researchers for 
additional avenues for future research; such as, Facebook groups, following Twitter hashtags to 
find advocates, joining advocate groups, finding groups of advocates who are also advocates for 
their own health, etc.   
With the many risks associated with tort law, we must treat every patient, with respect to 
their own strengths and weaknesses, the most optimal treatment environment while eliciting a 
functional change.  With that being said, it’s important to be aware of these risks that may arise 
and have the risk management program that works best for the specific facility or specifically for 
the service population.  Through this research, it is clear that the patient advocate or the facility’s 
patient advocacy program would be an effective in this role of protecting our patients and our 
practicing professionals who providing health care services.   
Future research should focus on identifying the enormous variety of patient advocates in 
our healthcare system.  During the research process, the researcher found that patient advocacy 
isn’t simply defined by ‘traditional’ and ‘non-traditional’ advocacy.  Some advocates are 
advocates for their own health disability, some advocates work for pharmaceutical companies to 
ensure patient focused research, some advocates work in mental and behavioral health, some 
serve as direct-care employees, some advocates are in an administrative role, the list goes on and 
on.  An exploratory analysis of the similarities and differences should be investigated with 
further research and a much larger sample population; likewise, the time aspect identified in the 
case reports should be further investigated.  Are direct-care employees more patient-oriented 
       
advocates?  Are indirect-care advocates able to achieve more for their patients administratively?  
What role does a secondary job position within the facility play? These are new questions to be 
investigated to add to our knowledge of the role of patient advocacy and as an administrative 
team, make qualitative changes to ensure the highest level of patient advocacy within an 
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